ABBV vs CI
By Alex · Tickerpine
AbbVie Inc. vs The Cigna Group, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | CI |
|---|---|---|
| Price | $295.03 | $297.00 |
| Market cap | $521.50B | $78.26B |
| P/E ratio | 50.7 | 13.1 |
| ROE | — | 15.65% |
| Profit margin | 15.67% | 2.09% |
| Revenue growth | 10.30% | 5.60% |
| Dividend yield | 2.35% | 2.10% |
| Beta | 0.19 | 0.25 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs CI in plain English
- ABBV is the bigger company — about 6.7× the market cap of CI.
- CI is cheaper on earnings (P/E 13.1 vs 50.7).
- ABBV is growing revenue faster (10% vs 6%).
- ABBV has the higher dividend yield (2.35% vs 2.10%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
CI return calculator
See what $1,000 in The Cigna Group would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.